Cargando…

Editorial: Prevention, diagnosis and treatment of rare disorders

Detalles Bibliográficos
Autores principales:	Cox, Timothy M., Tylki-Szymańska, Anna, Aymé, Ségolène, Dooms, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554627/ https://www.ncbi.nlm.nih.gov/pubmed/36249823 http://dx.doi.org/10.3389/fphar.2022.1026064

Ejemplares similares

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data
por: Chazal, Pierre Etienne, et al.
Publicado: (2021)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Orphanet Journal of Rare Diseases: Launch Editorial
por: Aymé, Ségolène, et al.
Publicado: (2006)

State of the art of rare disease activities in Europe: a EUCERD perspective
por: Aymé, Ségolène
Publicado: (2012)

Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2021)

The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community
por: Aymé, Ségolène, et al.
Publicado: (2014)

The importance of review articles in making the voice of rare diseases heard: OJRD’s 10th anniversary
por: Aymé, Ségolène
Publicado: (2016)

Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development
por: Liu, Zhichao, et al.
Publicado: (2020)

Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders
por: Dooms, M, et al.
Publicado: (2022)

Orphan Drugs, Compounded Medication and Pharmaceutical Commons
por: Hendrickx, Kim, et al.
Publicado: (2021)

Editorial: Inherited Protein Glycosylation Defects in Humans
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2022)

Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development
por: Liu, Zhichao, et al.
Publicado: (2022)

The European Union Committee of Experts on Rare Diseases (EUCERD): a new committee to help the European Commission advance in the field of rare disease policy
por: Moliner, Antoni Montserrat, et al.
Publicado: (2010)

Editorial: Functional Nanomaterials in Inflammatory Diseases: From Prevention to Diagnosis and Therapy
por: Evans, Colin E., et al.
Publicado: (2021)

Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding
por: Aymé, Ségolène, et al.
Publicado: (2015)

Evolution of national and European policies in the field of rare diseases and their impact over the past five years
por: Rodwell, Charlotte, et al.
Publicado: (2014)

Congenital Disorders of Glycosylation: What Clinicians Need to Know?
por: Lipiński, Patryk, et al.
Publicado: (2021)

New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community
por: Hivert, Virginie, et al.
Publicado: (2010)

Scope of centres of expertise for rare diseases in European countries where they exist
por: Rodwell, Charlotte, et al.
Publicado: (2012)

Classification of rare diseases: a worldwide effort to contribute to the International Classification of Diseases
por: Rath, Ana, et al.
Publicado: (2010)

Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders
por: Zong, Zhixian, et al.
Publicado: (2022)

A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
por: Abdallah, Khadidja, et al.
Publicado: (2021)

Congenital disorders of glycosylation: Prevalence, incidence and mutational spectrum in the Polish population
por: Lipiński, Patryk, et al.
Publicado: (2021)

Editorial: Classical and Modern Biotechnology Applied to the Treatment of Epilepsy and Anxiety Disorders
por: Beleboni, R. O., et al.
Publicado: (2022)

Editorial: Structure-Based Drug Design for Diagnosis and Treatment of Neurological Diseases
por: Ramsay, Rona R., et al.
Publicado: (2017)

WHO International Classification of Diseases (ICD) Revision Process: incorporating rare diseases into the classification scheme: state of art
por: Aymé, Ségolène, et al.
Publicado: (2010)

Editorial: Anti-inflammatory immunopharmacology in the prevention and treatment of major chronic diseases
por: Zhang, Qiuwang, et al.
Publicado: (2023)

Liver Involvement in Congenital Disorders of Glycosylation and Deglycosylation
por: Lipiński, Patryk, et al.
Publicado: (2021)

Rare diseases research in Europe: an overview based on data from the Orphanet database
por: Martin, Natalia, et al.
Publicado: (2010)

Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders
por: Hollak, Carla EM, et al.
Publicado: (2011)

Editorial: High altitude medicinal plants and their bioactive compounds for the prevention of oxidative stress-induced diseases and disorders
por: Semwal, Prabhakar, et al.
Publicado: (2023)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Editorial: Opioids and opioid-use disorders
por: de Guglielmo, Giordano, et al.
Publicado: (2023)

Editorial: Natural products, medicinal foods and complementary and alternative medicine as cancer-preventive agents
por: Zia-Ul-Haq, Muhammad, et al.
Publicado: (2023)

Editorial: Novel Approaches to the Neuropharmacology of Mood Disorders
por: Caruncho, Hector J., et al.
Publicado: (2019)

State of the art of services in Europe: where are the problems?
por: Aymé, Ségolène
Publicado: (2010)

Reviewer acknowledgement 2013
por: Aymé, Ségolène
Publicado: (2013)

Reviewer acknowledgement 2014
por: Aymé, Ségolène
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_onblmh8vrg7qscjgekvtd5paj3